Celebrating our 10th anniversary – Unlock our special offer today

Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Slovenia Cannabis public referendum approved with no date set ...
  • Kentucky - United States Medical cannabis amendment bill heads to governor ...
  • Brazil Senate approves making possession of cannabis a crime ...
  • Lithuania State budget allocates funds to testing THC levels in hemp ...
  • Slovenia Proposal approved for referendum on cannabis legalisation ...
  • Morocco Compulsory logo on cannabis products stipulated by ministry ...
  • United States HHS recommends rescheduling cannabis, now passes to DOJ ...
  • United States FDA’s Califf urges Congress to help regulate hemp-derived CBD ...
  • New Zealand ANTG Luna Oil verified for medical use ...
  • Ohio - United States Governor calls for ban on public cannabis consumption ...
  • United States No reason to delay cannabis scheduling decision, says FDA commissioner ...
  • Bulgaria Bill allowing for industrial hemp with up to 1% THC rejected ...
View all
News analysis

US FDA says lack of evidence for dietary-supplement pathway to CBD regulation

Written by || 26th January 2023 || News analysis | Cannabinoids | Food | Regulation and legislation | GeographiesNorth America United States

The US Food and Drug Administration (FDA) has rejected a regulatory pathway that would allow CBD products to be treated as food additives or dietary supplements.

The federal agency’s long-awaited pronouncement came today, 26th January, when it said it had denied three citizen petitions it received in the past three years asking it to issue regulations in this sense.

Read full article

Download the full news analysis

“US FDA says lack of evidence for dietary-supplement pathway to CBD regulation”








    I'm already a subscriber

    Login

    Tiziana Cauli

    Senior reporter
    Tiziana is an Italian journalist from Sardinia. She has worked for both international and local media in Italy, South Africa, France, Spain, the UK, Lebanon and Belgium. She also worked as a communications manager for several international NGOs in the humanitarian sector.

    Our Key Benefits

    The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

    CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

    • Stay informed of any legal and market change in the sector that impacts your organisation
    • Maximise resources by getting market and legal data analysis daily in one place
    • Make smart decisions by understanding how the regulatory and market landscape evolves
    • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

    Thanks for getting in touch with us

    Please leave your enquiry and we will get back to you within 24 hours


      Sign up to our newsletter

      Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis


        See more


        By signing up you agree to our Privacy Policy.